Monographie - Fosfomycin - Stabilis 4.0

Ultimo aggiornamento :
14/12/2024

Antibiotico

Fosfomycin

Iniezione

Stabilità in soluzione

Stabilità in miscela

Fattori che influenzano la stabilità

Compatibilità

metodo di iniezione

Bibliografia

pdf

Struttura chimica

Nome commerciale

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Fomicyt	Francia, Gran Bretagna
Fosfocina	Spagna
Fosmicin	Giappone
Ivozfo	Canada

Bibliografia

Iniezione

Bibliografia : Fosfomycin

	tipo	pubblicazione
1694	Rivista	Stahlmann SA, Frey OR, Kovar K-A. Stabilitätsstudie zu fosfomycin-dinatrium (Fosfocin° p.i. 5.0) in applikationsfertigen perfusorspritzen. Krankenhauspharmazie 1998 ; 19: 553-557.
3663	Laboratorio	Fosfomycine (Fosfomycine Panpharma®) - Résumé des caractéristiques du produit Panpharma 2011
3728	Rivista	Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3997	Rivista	Katip W. Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102
4055	Rivista	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145	Rivista	Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4440	Rivista	Omotani S, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M. Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion. Ann Nutr Metab 2018 ; 73: 227-233.
4458	Rivista	Kussmann M, Baumann A, Hauer S, Pichler P, Zeitlinger M, Wiesholzer M, Burgmann H, Poeppl W, Reznicek G. Compatibility of fosfomycin with different commercial peritoneal dialysis solutions. Eur J Clin Microbiol Infec Dis 2017 36:2237–2242.

Mentions Légales